Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Reactogenicity and safety of COVID-19 primary immunisation and booster vaccination regimens: a comparative observational cohort study

Fig. 3

Reactions after a first, second or third COVID-19 vaccination with different regimens. Local, systemic, and unsolicited reactions 14 days after the first, second, and third COVID-19 vaccination in participants with different vaccination regimens with consequences in hierarchical order, as multiple choice was possible. The consequence perceived as most serious is reported (from no consequence to medication intake, sick leave, ambulatory consultation, hospital outpatient consultation, and hospitalisation). Bars show the percentage of participants who reported at least one reaction in the respective category. Participants’ characteristics of each vaccine or vaccination regimen group are depicted in Table 1. PI mRNA = PI with BNT162b2 or mRNA-1273. PI vector: PI with ChAdOx1. PI mRNA/vector: PI with BNT162b2 or mRNA-1273 and ChAdOx1

Back to article page